535 related articles for article (PubMed ID: 30614282)
1. Short-term effects of metformin and myo-inositol in women with polycystic ovarian syndrome (PCOS): a meta-analysis of randomized clinical trials.
Facchinetti F; Orrù B; Grandi G; Unfer V
Gynecol Endocrinol; 2019 Mar; 35(3):198-206. PubMed ID: 30614282
[TBL] [Abstract][Full Text] [Related]
2. Effects of myo-inositol vs. metformin on hormonal and metabolic parameters in women with PCOS: a meta-analysis.
Fatima K; Jamil Z; Faheem S; Adnan A; Javaid SS; Naeem H; Mohiuddin N; Sajid A; Ochani S
Ir J Med Sci; 2023 Dec; 192(6):2801-2808. PubMed ID: 37148410
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.
Zhao H; Xing C; Zhang J; He B
Reprod Health; 2021 Aug; 18(1):171. PubMed ID: 34407851
[TBL] [Abstract][Full Text] [Related]
4. Short period-administration of myo-inositol and metformin on hormonal and glycolipid profiles in patients with polycystic ovary syndrome: a systematic review and updated meta-analysis of randomized controlled trials.
Zhang JQ; Xing C; He B
Eur Rev Med Pharmacol Sci; 2022 Mar; 26(6):1792-1802. PubMed ID: 35363325
[TBL] [Abstract][Full Text] [Related]
5. A systematic review and meta-analysis of randomized controlled trials comparing pioglitazone versus metformin in the treatment of polycystic ovary syndrome.
Du Q; Wang YJ; Yang S; Wu B; Han P; Zhao YY
Curr Med Res Opin; 2012 May; 28(5):723-30. PubMed ID: 22462531
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Myo-inositol on Anthropometric, Metabolic, and Endocrine Outcomes in PCOS Patients: a Meta-analysis of Randomized Controlled Trial.
Jethaliya H; Gajjar N; Patel V; Deshpande S; Patel R
Reprod Sci; 2022 Aug; 29(8):2282-2298. PubMed ID: 35477841
[TBL] [Abstract][Full Text] [Related]
7. Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.
Greff D; Juhász AE; Váncsa S; Váradi A; Sipos Z; Szinte J; Park S; Hegyi P; Nyirády P; Ács N; Várbíró S; Horváth EM
Reprod Biol Endocrinol; 2023 Jan; 21(1):10. PubMed ID: 36703143
[TBL] [Abstract][Full Text] [Related]
8. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials.
Unfer V; Facchinetti F; Orrù B; Giordani B; Nestler J
Endocr Connect; 2017 Nov; 6(8):647-658. PubMed ID: 29042448
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of inositol, metformin and their combination in women with PCOS undergoing assisted reproduction: systematic review and meta-analysis.
Unanyan A; Pivazyan L; Krylova E; Eskin A; Zakaryan A; Sarkisova A; Ishchenko A
Gynecol Endocrinol; 2022 Dec; 38(12):1035-1046. PubMed ID: 36285403
[TBL] [Abstract][Full Text] [Related]
10. An investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: a meta-analysis of randomised controlled trials.
Sun J; Yuan Y; Cai R; Sun H; Zhou Y; Wang P; Huang R; Xia W; Wang S
BMJ Open; 2015 Mar; 5(3):e007280. PubMed ID: 25818277
[TBL] [Abstract][Full Text] [Related]
11. Comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome: a randomized controlled clinical trial.
Shokrpour M; Foroozanfard F; Afshar Ebrahimi F; Vahedpoor Z; Aghadavod E; Ghaderi A; Asemi Z
Gynecol Endocrinol; 2019 May; 35(5):406-411. PubMed ID: 30608001
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of metformin combined with simvastatin in the treatment of polycystic ovary syndrome: A meta-analysis and systematic review.
Liu Y; Shao Y; Xie J; Chen L; Zhu G
Medicine (Baltimore); 2021 Aug; 100(31):e26622. PubMed ID: 34397797
[TBL] [Abstract][Full Text] [Related]
13. The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial.
Soldat-Stanković V; Popović-Pejičić S; Stanković S; Prtina A; Malešević G; Bjekić-Macut J; Livadas S; Ognjanović S; Mastorakos G; Micić D; Macut D
J Endocrinol Invest; 2022 Mar; 45(3):583-595. PubMed ID: 34665453
[TBL] [Abstract][Full Text] [Related]
14. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.
Lord JM; Flight IH; Norman RJ
Cochrane Database Syst Rev; 2003; (3):CD003053. PubMed ID: 12917943
[TBL] [Abstract][Full Text] [Related]
15. WITHDRAWN: Insulin-sensitising drugs for polycystic ovary syndrome.
Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
Cochrane Database Syst Rev; 2009 Jul; (3):CD003053. PubMed ID: 19588338
[TBL] [Abstract][Full Text] [Related]
16. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome.
Costello M; Shrestha B; Eden J; Sjoblom P; Johnson N
Cochrane Database Syst Rev; 2007 Jan; (1):CD005552. PubMed ID: 17253562
[TBL] [Abstract][Full Text] [Related]
17. Effect of metformin on clinical, metabolic and endocrine outcomes in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials.
Patel R; Shah G
Curr Med Res Opin; 2017 Sep; 33(9):1545-1557. PubMed ID: 28058854
[TBL] [Abstract][Full Text] [Related]
18. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
[TBL] [Abstract][Full Text] [Related]
19. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
Cochrane Database Syst Rev; 2009 Oct; (4):CD003053. PubMed ID: 19821299
[TBL] [Abstract][Full Text] [Related]
20. Metformin and glitazones: do they really help PCOS patients?
Pillai A; Bang H; Green C
J Fam Pract; 2007 Jun; 56(6):444-53. PubMed ID: 17543254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
